Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Blankenstein

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 1998
Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysisP T Daniel, A Kroidl, S Cayeux, et al.
Cancer Research|February 15, 1993
Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvantH Hock, M Dorsch, U Kunzendorf, et al.
Human Gene Therapy|May 16, 2000
Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotypeW Uckert, C Becker, M Gladow, et al.
Gene Therapy|August 19, 2007
In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccineS Cayeux, B Bukarica, C Buschow, et al.
European Journal of Immunology|May 1, 1992
Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reactionC Platzer, G Richter, K Uberla, et al.
Nature Medicine|October 9, 2001
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assayC Becker, H Pohla, B Frankenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
European School of Oncology position paper. Gene therapy for the medical oncologistM Blaese, T Blankenstein, M Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expressionF Salazar-Onfray, M Petersson, L Franksson, et al.
Nucleic Acids Research|November 11, 1989
Lack of correlation between BglII RFLP in the human interleukin 6 gene and rheumatoid arthritisT Blankenstein, H D Volk, C Techert-Jendrusch, et al.
Cancer Research|September 15, 1993
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltrationG Richter, S Krüger-Krasagakes, G Hein, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 1998
Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysisP T Daniel, A Kroidl, S Cayeux, et al.
Cancer Research|February 15, 1993
Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvantH Hock, M Dorsch, U Kunzendorf, et al.
Human Gene Therapy|May 16, 2000
Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotypeW Uckert, C Becker, M Gladow, et al.
Gene Therapy|August 19, 2007
In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccineS Cayeux, B Bukarica, C Buschow, et al.
European Journal of Immunology|May 1, 1992
Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reactionC Platzer, G Richter, K Uberla, et al.
Nature Medicine|October 9, 2001
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assayC Becker, H Pohla, B Frankenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
European School of Oncology position paper. Gene therapy for the medical oncologistM Blaese, T Blankenstein, M Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expressionF Salazar-Onfray, M Petersson, L Franksson, et al.
Nucleic Acids Research|November 11, 1989
Lack of correlation between BglII RFLP in the human interleukin 6 gene and rheumatoid arthritisT Blankenstein, H D Volk, C Techert-Jendrusch, et al.
Cancer Research|September 15, 1993
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltrationG Richter, S Krüger-Krasagakes, G Hein, et al.
Pageof 10